Vaccine for recurrent urinary tract infections

Recurrent urinary tract infections (RUTIs) are relatively common in the 50 – 60% of women who develop this type of infection. A Spanish study favours the use of a bacterial-based vaccine called Uromune® containing an inactivated bacterial cell suspension of selected strains of Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, and Enterococcus faecalis.

Used for a period of 6 months the therapeutic vaccine was an effective strategy to reduce frequency, duration, severity, and costs of RUTIs.